Tobias Obejum Apinjoh, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria, Falciparum | 21 | 2024 | 1075 | 4.540 |
Why?
|
| Plasmodium falciparum | 16 | 2024 | 1741 | 2.630 |
Why?
|
| Malaria | 15 | 2023 | 1241 | 2.390 |
Why?
|
| Cameroon | 23 | 2024 | 79 | 2.360 |
Why?
|
| Insecticide-Treated Bednets | 5 | 2024 | 70 | 1.800 |
Why?
|
| Protozoan Proteins | 5 | 2024 | 844 | 1.740 |
Why?
|
| Antigens, Protozoan | 3 | 2024 | 315 | 1.600 |
Why?
|
| Pregnancy Complications, Parasitic | 5 | 2024 | 62 | 1.490 |
Why?
|
| Parasitemia | 9 | 2022 | 165 | 1.440 |
Why?
|
| Insecticides | 2 | 2022 | 200 | 1.440 |
Why?
|
| Antimalarials | 9 | 2022 | 908 | 1.370 |
Why?
|
| Drug Resistance | 6 | 2022 | 1595 | 1.050 |
Why?
|
| Hospitals, District | 1 | 2024 | 114 | 0.880 |
Why?
|
| Anopheles | 2 | 2022 | 193 | 0.720 |
Why?
|
| Plasmodium | 1 | 2023 | 248 | 0.690 |
Why?
|
| Urine | 1 | 2021 | 363 | 0.670 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2024 | 790 | 0.620 |
Why?
|
| Prenatal Care | 2 | 2024 | 1159 | 0.560 |
Why?
|
| Gene Deletion | 1 | 2024 | 2673 | 0.550 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2015 | 36 | 0.500 |
Why?
|
| Suburban Population | 1 | 2015 | 54 | 0.490 |
Why?
|
| Artemisinins | 4 | 2019 | 217 | 0.390 |
Why?
|
| Sulfadoxine | 2 | 2022 | 46 | 0.380 |
Why?
|
| Pyrimethamine | 2 | 2022 | 94 | 0.370 |
Why?
|
| Cross-Sectional Studies | 14 | 2024 | 26375 | 0.360 |
Why?
|
| Plasmodium malariae | 2 | 2022 | 13 | 0.350 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 582 | 0.340 |
Why?
|
| Mosquito Control | 2 | 2024 | 110 | 0.330 |
Why?
|
| Genetic Variation | 6 | 2024 | 6606 | 0.320 |
Why?
|
| Interleukin-10 | 1 | 2014 | 1184 | 0.310 |
Why?
|
| Seasons | 3 | 2024 | 1526 | 0.300 |
Why?
|
| Rural Population | 2 | 2015 | 2318 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 2003 | 0.260 |
Why?
|
| Africa South of the Sahara | 5 | 2022 | 751 | 0.250 |
Why?
|
| Drug Combinations | 3 | 2022 | 2079 | 0.250 |
Why?
|
| Prevalence | 7 | 2024 | 15872 | 0.240 |
Why?
|
| Young Adult | 14 | 2024 | 60049 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2023 | 16028 | 0.220 |
Why?
|
| Genome, Protozoan | 1 | 2024 | 153 | 0.220 |
Why?
|
| False Negative Reactions | 1 | 2024 | 575 | 0.220 |
Why?
|
| Dihydropteroate Synthase | 1 | 2023 | 27 | 0.210 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 4250 | 0.210 |
Why?
|
| Child, Preschool | 10 | 2024 | 42650 | 0.210 |
Why?
|
| Gene Frequency | 5 | 2021 | 3617 | 0.210 |
Why?
|
| Anemia | 3 | 2017 | 1519 | 0.210 |
Why?
|
| Infant | 8 | 2024 | 36510 | 0.210 |
Why?
|
| Helminthiasis | 2 | 2016 | 81 | 0.190 |
Why?
|
| Antigenic Variation | 1 | 2021 | 118 | 0.190 |
Why?
|
| Adolescent | 12 | 2024 | 89184 | 0.180 |
Why?
|
| Malaria Vaccines | 1 | 2021 | 164 | 0.170 |
Why?
|
| Erythrocytes | 3 | 2017 | 2421 | 0.170 |
Why?
|
| Cytokines | 1 | 2013 | 7445 | 0.150 |
Why?
|
| Child | 11 | 2024 | 80891 | 0.150 |
Why?
|
| Pregnancy | 9 | 2024 | 30200 | 0.150 |
Why?
|
| Microscopy | 2 | 2021 | 909 | 0.150 |
Why?
|
| Pregnant Women | 1 | 2022 | 577 | 0.140 |
Why?
|
| Plasmodium ovale | 1 | 2017 | 13 | 0.140 |
Why?
|
| Alleles | 4 | 2017 | 6892 | 0.140 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2017 | 95 | 0.130 |
Why?
|
| Humans | 35 | 2024 | 768393 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 620 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1195 | 0.130 |
Why?
|
| Adult | 15 | 2024 | 223640 | 0.130 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2017 | 182 | 0.130 |
Why?
|
| Malaria, Cerebral | 1 | 2017 | 136 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 18048 | 0.120 |
Why?
|
| Female | 21 | 2024 | 397089 | 0.120 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 303 | 0.120 |
Why?
|
| DNA, Protozoan | 1 | 2015 | 228 | 0.120 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2015 | 767 | 0.120 |
Why?
|
| Family Characteristics | 1 | 2019 | 1003 | 0.110 |
Why?
|
| Birth Weight | 1 | 2022 | 2114 | 0.110 |
Why?
|
| Geography | 1 | 2015 | 654 | 0.100 |
Why?
|
| Perinatal Care | 1 | 2014 | 245 | 0.100 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 2961 | 0.090 |
Why?
|
| Africa | 2 | 2024 | 726 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2022 | 3203 | 0.090 |
Why?
|
| Genome, Human | 3 | 2021 | 4450 | 0.090 |
Why?
|
| Genotype | 2 | 2015 | 13042 | 0.080 |
Why?
|
| Middle Aged | 6 | 2024 | 223491 | 0.080 |
Why?
|
| Male | 11 | 2024 | 364902 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2014 | 2185 | 0.080 |
Why?
|
| Genome | 1 | 2017 | 1747 | 0.080 |
Why?
|
| Haplotypes | 3 | 2021 | 2724 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1893 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2023 | 4047 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2017 | 22296 | 0.070 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2008 | 64 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2021 | 6277 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2017 | 5404 | 0.070 |
Why?
|
| Aged | 4 | 2024 | 171562 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 14784 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 6085 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 14737 | 0.060 |
Why?
|
| Selection, Genetic | 2 | 2021 | 877 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 12778 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2015 | 9682 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 59686 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2024 | 473 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2022 | 26411 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2022 | 784 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 3231 | 0.040 |
Why?
|
| Malawi | 1 | 2019 | 309 | 0.040 |
Why?
|
| Ghana | 1 | 2019 | 319 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 948 | 0.040 |
Why?
|
| Ethiopia | 1 | 2019 | 482 | 0.040 |
Why?
|
| Phenotype | 1 | 2015 | 16721 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 169337 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2017 | 224 | 0.030 |
Why?
|
| Gene Flow | 1 | 2016 | 79 | 0.030 |
Why?
|
| Helminths | 1 | 2016 | 39 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2021 | 942 | 0.030 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2017 | 209 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2021 | 1337 | 0.030 |
Why?
|
| Genomics | 2 | 2024 | 5916 | 0.030 |
Why?
|
| Epitopes | 1 | 2021 | 2525 | 0.030 |
Why?
|
| Asia, Southeastern | 1 | 2014 | 115 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 7861 | 0.030 |
Why?
|
| Ownership | 1 | 2017 | 344 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 1216 | 0.030 |
Why?
|
| Topography, Medical | 1 | 2012 | 37 | 0.030 |
Why?
|
| Colorimetry | 1 | 2012 | 151 | 0.020 |
Why?
|
| Risk Factors | 2 | 2015 | 74962 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 436 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2019 | 2630 | 0.020 |
Why?
|
| Blood | 1 | 2012 | 597 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3827 | 0.020 |
Why?
|
| Phylogeny | 1 | 2017 | 2843 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2021 | 54920 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2046 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 2819 | 0.020 |
Why?
|
| Parasite Egg Count | 1 | 2007 | 29 | 0.020 |
Why?
|
| Gravitation | 1 | 2007 | 82 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2008 | 190 | 0.020 |
Why?
|
| Altitude | 1 | 2008 | 164 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2012 | 1532 | 0.020 |
Why?
|
| Mutation | 2 | 2023 | 30228 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2015 | 2784 | 0.010 |
Why?
|
| Rural Health Services | 1 | 2008 | 393 | 0.010 |
Why?
|
| Maternal Age | 1 | 2007 | 809 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2007 | 1157 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 1506 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2007 | 977 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3813 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6241 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3164 | 0.010 |
Why?
|
| Gestational Age | 1 | 2007 | 3615 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2012 | 6430 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 24318 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15939 | 0.010 |
Why?
|